⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10775774 | 0.87 | — | — | |
| SCHEMBL157843 | 0.79 | — | — | |
| SCHEMBL6589902 | 0.77 | — | — | |
| SCHEMBL10772784 | 0.74 | — | — | |
| SCHEMBL5432 | 0.73 | — | — | |
| SCHEMBL8397539 | 0.73 | — | — | |
| SCHEMBL23176 | 0.72 | — | — | |
| SCHEMBL6923098 | 0.72 | — | — | |
| SCHEMBL6352627 | 0.72 | — | — | |
| SCHEMBL2431613 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1693 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4396181-A1 | 2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE P2X7 ANTAGONISTS | Breye Therapeutics ApS (DK) | 2024-07-10 | — | — | EP | claimed |
| WO-2024118801-A1 | LINEAR HETEROARYL DIAMIDE IRE1/XBP1S ACTIVATORS | PROTEGO BIOPHARMA, INC. (US) | 2024-06-06 | — | — | WO | claimed |
| CN-118084980-A | Organic light-emitting material | 北京夏禾科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-118063520-A | Organic luminescent material containing 3-deuterium substituted isoquinoline ligand | 北京夏禾科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118019736-A | Molecular gel compound designed based on cereblon protein and application thereof | 标新生物医药科技(上海)有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117881675-A | 2, 4-dihydro-3H-1, 2, 4-triazol-3-one P2X7 antagonists | 布雷耶疗法有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-110770214-B | Heterocyclic P2X7 antagonists | 布雷耶疗法有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-113121609-B | Metal complex, electroluminescent device comprising same and application of metal complex | 北京夏禾科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-11937499-B2 | Aromatic amine derivative and organic electroluminescent devices containing the same | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2024-03-19 | — | — | US | claimed |
| WO-2024051766-A1 | MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-03-14 | — | — | WO | claimed |
| CN-1353700-A | Isothiazole carboxamides and their use as microbicides | BAYER AGROCHEM KK (JP) | 2002-06-12 | — | — | CN | claimed |
| EP-1185519-A1 | ISOTHIAZOLECARBOXAMIDES AND THEIR USE AS MICROBICIDES | NIHON BAYER AGROCHEM K.K. (JP) | 2002-03-13 | — | — | EP | claimed |
| US-6326359-B1 | PURINE DERIVATIVES | PFIZER INC | 2001-12-04 | — | — | US | claimed |
| EP-1121372-A1 | ADENINE DERIVATIVES | Pfizer Limited (GB) | 2001-08-08 | — | — | EP | claimed |
| CN-1285820-A | Metabotropic glutamate receptor antagonists for the treatment of central nervous system disorders | NPS PHARMA INC (US) | 2001-02-28 | — | — | CN | claimed |
| WO-2000073290-A1 | ISOTHIAZOLECARBOXAMIDES AND THEIR USE AS MICROBICIDES | NIHON BAYER AGROCHEM K.K. (JP) | 2000-12-07 | — | — | WO | claimed |
| WO-2000023457-A1 | ADENINE DERIVATIVES | PFIZER LIMITED (GB) | 2000-04-27 | — | — | WO | claimed |
| US-4500538-A | Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure | MERCK & CO., INC. (US) | 1985-02-19 | — | — | US | claimed |
| US-4470991-A | Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure | MERCK & CO., INC. (US) | 1984-09-11 | — | — | US | claimed |
| US-3962244-A | LOWERING OF BLOOD-SUGAR LEVELS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | claimed |